secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE)
CIK:        0001035443
Form:       8-K
Filed at:   2025-03-06T23:59:59+00:00
Accession:  0001104659-25-021383
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alexandria RE elects Claire Aldridge, PhD to board, effective March 14, 2025
----------------------------------------------------------------------------

- Board size increased from 8 to 9; Aldridge serves until 2025 annual meeting.
- She was chief strategy officer at Form Bio, a Colossal Biosciences spinout, with 25+ years in life science.
- Upon election, receives 1,000 restricted shares vesting on second anniversary.
- Appointed to Life Science Committee; determined independent under NYSE and SEC rules.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1035443/000110465925021383/0001104659-25-021383-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1035443/000110465925021383/tm258282d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-021383

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer